BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 31073201)

  • 1. Immunosuppression Reduces Lung Injury Caused by Mycoplasma pneumoniae Infection.
    Shi S; Zhang X; Zhou Y; Tang H; Zhao D; Liu F
    Sci Rep; 2019 May; 9(1):7147. PubMed ID: 31073201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteomic and mechanistic study of Qingxuan Tongluo formula and curcumin in the treatment of Mycoplasma pneumoniae pneumonia.
    Wei L; Zhong W; Sun T; Li H; Sun T; Han Y; Sun D; Li X
    Biomed Pharmacother; 2021 Jan; 133():110998. PubMed ID: 33378995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Baicalin relieves
    Zhang H; Li X; Wang J; Cheng Q; Shang Y; Wang G
    Mol Med Rep; 2021 Aug; 24(2):. PubMed ID: 34109422
    [No Abstract]   [Full Text] [Related]  

  • 4. High Mycoplasma pneumoniae loads and persistent long-term Mycoplasma pneumoniae DNA in lower airway associated with severity of pediatric Mycoplasma pneumoniae pneumonia.
    Liu J; Zhao F; Lu J; Xu H; Liu H; Tang X; Yang H; Zhang J; Zhao S
    BMC Infect Dis; 2019 Dec; 19(1):1045. PubMed ID: 31823740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the ameliorative effects of Qingfei Tongluo formula and azithromycin on Mycoplasma pneumoniae pneumonia.
    Xiao Z; Jiang Y; Gao X; Lin S; Lin Y; Liu X; Tan D; Jiang Z
    J Nat Med; 2017 Oct; 71(4):685-692. PubMed ID: 28664473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of risk factors of bronchial mucus plugs in children with Mycoplasma pneumoniae pneumonia.
    Zhang J; Wang T; Li R; Ji W; Yan Y; Sun Z; Tan J; Wu J; Huang L; Chen Z
    BMC Infect Dis; 2021 Jan; 21(1):67. PubMed ID: 33441105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Protective Effect of Naringenin on Airway Remodeling after
    Lin Y; Tan D; Kan Q; Xiao Z; Jiang Z
    Mediators Inflamm; 2018; 2018():8753894. PubMed ID: 29849498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation Between the Clinical Severity, Bacterial Load, and Inflammatory Reaction in Children with Mycoplasma Pneumoniae Pneumonia.
    Zhang C; Zhang Q; Du JL; Deng D; Gao YL; Wang CL; Zhao HJ; Guo Q; Fu Z; Tian DY
    Curr Med Sci; 2020 Oct; 40(5):822-828. PubMed ID: 33123897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identify clinical factors related to Mycoplasma pneumoniae pneumonia with hypoxia in children.
    Ling Y; Zhang T; Guo W; Zhu Z; Tian J; Cai C; Xu Y
    BMC Infect Dis; 2020 Jul; 20(1):534. PubMed ID: 32698769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mycoplasma pneumoniae induces allergy by producing P1-specific immunoglobulin E.
    Ye Q; Mao JH; Shu Q; Shang SQ
    Ann Allergy Asthma Immunol; 2018 Jul; 121(1):90-97. PubMed ID: 29555351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin 17A as a good predictor of the severity of Mycoplasma pneumoniae pneumonia in children.
    Yang M; Meng F; Wang K; Gao M; Lu R; Li M; Zhao F; Huang L; Zhang Y; Cheng G; Wang X
    Sci Rep; 2017 Oct; 7(1):12934. PubMed ID: 29021577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased Serum Interleukin-10 but not Interleukin-4 Level in Children with Mycoplasma pneumoniae Pneumonia.
    Medjo B; Atanaskovic-Markovic M; Nikolic D; Radic S; Lazarevic I; Cirkovic I; Djukic S
    J Trop Pediatr; 2017 Aug; 63(4):294-300. PubMed ID: 28057814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age-specific Mycoplasma pneumoniae pneumonia-associated myocardial damage in children.
    Li CM; Gu L; Yin SJ; Yang R; Xie Y; Guo XZ; Fu YX; Cheng D
    J Int Med Res; 2013 Oct; 41(5):1716-23. PubMed ID: 24026772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro and in vivo study of andrographolide nanoparticles for the treatment of Mycoplasma pneumoniae pneumonia.
    Wang L; Liu L; Cheng S; Zhu J; Xie H; Zhao W
    Biochem Biophys Res Commun; 2024 Feb; 698():149540. PubMed ID: 38266313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation on blood coagulation and C-reactive protein level among children with mycoplasma pneumoniae pneumonia by different chest imaging findings.
    Wang J; Mao J; Chen G; Huang Y; Zhou J; Gao C; Jin D; Zhang C; Wen J; Sun J
    Medicine (Baltimore); 2021 Jan; 100(3):e23926. PubMed ID: 33545964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of the Mycoplasma pneumoniae/Interleukin-8/Neutrophil Axis in the Pathogenesis of Pneumonia.
    Chen Z; Shao X; Dou X; Zhang X; Wang Y; Zhu C; Hao C; Fan M; Ji W; Yan Y
    PLoS One; 2016; 11(1):e0146377. PubMed ID: 26752656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significance changes in the levels of myocardial enzyme in the child patients with Mycoplasma Pneumoniae Pneumonia.
    Qi X; Sun X; Li X; Kong D; Zhao L
    Cell Mol Biol (Noisy-le-grand); 2020 Sep; 66(6):41-45. PubMed ID: 33040783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune response plays a role in
    Zhu Y; Luo Y; Li L; Jiang X; Du Y; Wang J; Li H; Gu H; Li D; Tang H; Qin H; Xu C; Liu Y; Zhao D; Guo Y; Liu F
    Front Immunol; 2023; 14():1189647. PubMed ID: 37304280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ameliorative effects of Qingfei Tongluo formula on experimental mycoplasmal pneumonia in mice.
    Jiang YH; Yu JE; Guo AH; Li X; Lin Y; Jiang ZY; Xiao Z
    J Nat Med; 2016 Apr; 70(2):145-51. PubMed ID: 26590157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma soluble B7-H3 levels for severity evaluation in pediatric patients with Mycoplasma pneumoniae pneumonia.
    Xu Y; Yu L; Hao C; Wang Y; Zhu C; Ji W; Li Y; Li G; Chen Z; Yan Y
    Int Immunopharmacol; 2019 Aug; 73():163-171. PubMed ID: 31100711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.